MedPath

Women Initiating New Goals of Safety

Phase 1
Completed
Conditions
Intimate Partner Violence
Interventions
Behavioral: Multi-media WINGS
Behavioral: Caseworker Delivered WINGS
Registration Number
NCT01788579
Lead Sponsor
Columbia University
Brief Summary

This study aims to conduct a randomized controlled trial that will test the feasibility and preliminary effect of a multimedia version of a computerized multimedia intimate partner violence (IPV) prevention service tool designed to increase identification of IPV victimization and to improve linkages to IPV-related services among female offenders under court supervision or probation, compared to a non-media version of the same IPV screening, brief intervention and referral service delivered by a case manager. The study addresses the following: Primary study aims

1. To design and beta-test a Computerized Multimedia IPV Screening, Brief Intervention and Referral Service tool for female offenders under court supervision or probation.

2. To obtain preliminary estimates of the effects of the Computerized Multimedia versus the Case Manager IPV service conditions on identification of different types of IPV during the service session and on access to and utilization of IPV services over the three-month follow-up period.

3. To examine and enhance the feasibility (recruitment, enrollment, fidelity of service delivery, client satisfaction, safety, and retention) for a future larger scale R01 study.

Secondary study aim

4. To obtain estimates of the effects of the Computerized Multimedia versus the Case Manager IPV service conditions on recidivism, adherence to drug treatment (e.g., attendance, completion) and abstinence of substance use over the follow-up period, controlling for baseline outcomes.

Detailed Description

Intimate partner violence is a serious public health problem that disproportionately affects drug-involved female offenders under community supervision. Moreover, accumulating research has found strong associations linking experiencing intimate partner violence (IPV) and continued drug use among women in drug treatment. This research suggests that failure to prevent IPV among drug-involved female offenders under community supervision likely to result in higher rates of relapse, treatment attrition and recidivism and underscores the need to address the IPV service needs among the rapidly growing population of female offenders under community supervision. Computerized multimedia IPV prevention service tools have been shown to be feasible and effective in conducting screening, brief intervention and referral for IPV in medical care settings. The proposed services research addresses the significant public health problem of IPV victimization and a co-occurring risk for relapse and recidivism among drug-involved female offenders under court supervision or probation. The proposed computerized tool employs a self-paced, multimedia format to conduct IPV screening, brief intervention and IPV-related service referrals that is informed by best IPV screening and referral practices and previous intervention research. This innovative tool represents a cost-effective option that may implemented with greater fidelity and result in better client satisfaction and IPV prevention outcomes. Furthermore, if found to be effective in identifying IPV and improving linkage to IPV services, this cost effective computerized service tool may be scaled up with ease and speed in court and probation settings in New York State and nationwide.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
209
Inclusion Criteria
  • She is 18 or older
  • She is currently court supervision at Bronx Community Solutions or a drug treatment court or she is currently on probation.
  • She reports using any illicit drug or drinking 4 or more alcoholic drinks in a 6-hour period in the past 90 days or she has been in alcohol or drug treatment in the past 6 months OR if she report attending any drug or alcohol treatment in the past 6 months.
  • She reports having had an ongoing intimate, dating or sexual relationship with a male or female partner that lasted 3 or more months in the past year.
  • She lives within a 90-minute commute of 125th and Broadway
Read More
Exclusion Criteria
  • Ability to speak and understand English is not sufficient to participate in assessments or intervention sessions.
  • Inability to complete informed consent process due to a psychiatric or cognitive impairment.
  • The participant is unwilling or unable to commit to completing all the activities in the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Multimedia WINGSMulti-media WINGSA one-hour session of a self-paced multimedia IPV screening, brief intervention and referral service delivered on a computer.
Caseworker Delivered WINGSCaseworker Delivered WINGSA one-hour session of IPV screening, brief intervention and referral service delivered by a case manager.
Primary Outcome Measures
NameTimeMethod
Utilization of IPV servicesUp to 3 months from baseline
Number of subjects with identified Intimate Partner Violence (IPV)Up to 3 months from baseline

If participants score a 20 or higher on the Women's Experience with Battering (WEB) survey, if they indicate yes to any of the Partner Abuse Interview or Partner Violence Screen (PVS), the tool will inform participants that they are at risk of IPV. If participants indicate yes to any severe IPV items, the tool will indicate that they are at risk of life-threatening IPV and should consider taking immediate steps to reduce their risks for IPV. All other participants will be informed that based on the answers, they do not appear to be at risk for IPV at present, but that they may learn strategies to prevent IPV in the session.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Brooklyn Probation

🇺🇸

Brooklyn, New York, United States

Bronx Community Solutions

🇺🇸

New York City, New York, United States

Bronx Probation

🇺🇸

New York City, New York, United States

© Copyright 2025. All Rights Reserved by MedPath